Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
Sangeetha Iyer, Ethan Perlstein(Technological University of Pereira)
Cited by 78
Related Papers
Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic Implications
|Annals of Neurology|2021|57
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
|bioRxiv (Cold Spring Harbor Laboratory)|2019|32